QT Imaging H1 revenue up 116% to $14M, 28 scanners shipped; FY26 guidance ~$39M

QT IMAGING HOLDINGS, INC.

H1 2026 revenue $14.0M, up 116% YoY; 28 Breast Acoustic CT scanners shipped, double prior-year period.
FY2026 revenue guidance ~$39M vs $18.9M in 2025 and $4.9M in 2024.
Completed $10M public offering; extended senior secured term loan to March 31, 2029; cash ~$14.2M as of Aug 7, 2026.
FDA inspection with zero Form 483 observations; new clearances for enhanced scanner and volumetric lesion-assessment software.
CPT Category III code effective Jan 1, 2027; regulatory approvals in Saudi Arabia, UAE, and Israel.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.